Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 2Choledocholithiasis 2Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Dysplasia 1Triple Negative Breast Neoplasms 1Papillomavirus Infections 1Pancreatitis 1Pain 1Neoplasm Metastasis 1Choledochal Cyst 1Cholangitis 1Cholangiocarcinoma 1Carcinoma in Situ 1Carcinoma 1Agnosia 1

Interventions

Midazolam 2Transplantation 1Propofol 1Meperidine 1Laparoscopy 1Ketamine 1Etomidate 1Conversion to Open Surgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Choledochal Cyst × Meperidine × Clear all
NCT06111872 2025-03-25

Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography.

National University of Malaysia

Phase 2 Completed
90 enrolled
Gastrointestinal

Cholangitis, Pancreatic Neoplasms, Choledochal Cyst, Choledocholithiasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡